Chemoinformaics analysis of E-2-Tetradecen-1-ol
Molecular Weight | 212.377 | nRot | 11 |
Heavy Atom Molecular Weight | 184.153 | nRig | 0 |
Exact Molecular Weight | 212.214 | nRing | 0 |
Solubility: LogS | -0.387 | nHRing | 0 |
Solubility: LogP | 1.041 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 42.8522 |
nHD | 1 | BPOL | 28.0898 |
QED | 0.537 |
Synth | 2.361 |
Natural Product Likeliness | 0.632 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.909 |
HIA | 0.007 |
CACO-2 | -4.192 |
MDCK | 0.0000823 |
BBB | 0.883 |
PPB | 0.212069 |
VDSS | 1.102 |
FU | 0.664324 |
CYP1A2-inh | 0.272 |
CYP1A2-sub | 0.741 |
CYP2c19-inh | 0.036 |
CYP2c19-sub | 0.776 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.385 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.398 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.235 |
CL | 11.28 |
T12 | 0.771 |
hERG | 0.022 |
Ames | 0.008 |
ROA | 0.027 |
SkinSen | 0.162 |
Carcinogencity | 0.27 |
EI | 0.994 |
Respiratory | 0.093 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.797128 |